BIOSTAGE INC NEW (BSTG) earnings
Quarterly and annual BSTG reports and results, each read against the price at its own news timestamp. Back to the BSTG overview →
13 measured BSTG earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K Harvard Apparatus Regene For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Harvard Apparatus Regene For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | — | — | |
| Form 10-K Harvard Apparatus Regene For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Harvard Apparatus Regene For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results | Press release | — | — | |
| Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results | Press release | — | — |
Keep exploring
More BSTG: analyst actions → · SEC filings → · BSTG overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Strongbridge Biopharma plc - Ordinary Shares (SBBP) | 537 | -0.32% | 36% |
| ZAFGEN INC (ZFGN) | 534 | -0.23% | 42% |
| OBALON THERAPEUTICS (OBLN) | 532 | -0.09% | 42% |
| Oncolytics Biotech Inc. - Common Shares (ONCY) | 530 | -0.06% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.